Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
29,997,317
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
1,247,413
-
Shares change
-
+120,692
-
Total reported value, excl. options
-
$5,915,513
-
Value change
-
+$557,521
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$4.75
Significant Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q3 2020
21 filings reported holding EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share as of Q3 2020.
EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,247,413 shares
of 29,997,317 outstanding shares and own 4.2% of the company stock.
Largest 10 shareholders include Puissance Capital Management LP (774,400 shares), VANGUARD GROUP INC (120,228 shares), BlackRock Inc. (80,135 shares), Atom Investors LP (70,478 shares), RENAISSANCE TECHNOLOGIES LLC (61,136 shares), WINTON GROUP Ltd (27,759 shares), GEODE CAPITAL MANAGEMENT, LLC (26,438 shares), BANK OF MONTREAL /CAN/ (18,808 shares), UBS Group AG (18,501 shares), and Strategic Wealth Designers (15,333 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.